Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis
- PMID: 32217961
- PMCID: PMC8900872
- DOI: 10.1097/AOG.0000000000003812
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis
Comment in
-
In Reply.Obstet Gynecol. 2020 Apr;135(4):975-976. doi: 10.1097/AOG.0000000000003813. Obstet Gynecol. 2020. PMID: 32217962 No abstract available.
Comment on
-
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.Obstet Gynecol. 2019 Nov;134(5):921-931. doi: 10.1097/AOG.0000000000003503. Obstet Gynecol. 2019. PMID: 31599845 Free PMC article.
References
-
- Crofts N, Nigro L, Oman K, Stevenson E, Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 1997;92:999–1005. - PubMed
-
- Metzger DS, Woody GE, McLellan AT, Druley P, Navaline H, DePhilippis D, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993;6:1049–56. - PubMed
-
- Brugal M, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, De La Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005;100:981–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
